PTF1A and pancreatic neoplasm: Next, we assessed miR181ab1 function in pancreatic tumor development using the Ptf1a+/CreKras+/LSL-G12DTrp53fl/fl (KPC181fl/fl) mutant model in which PDAC develops with 100% penetrance 6–8 weeks after birth (Figure 3G) (47).